Latest Articles

Publication Date
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace

Published: June 2, 2025, 11:48 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire

Published: June 2, 2025, 6:32 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo Finance

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo Finance

Published: June 2, 2025, 6:30 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo

Published: June 2, 2025, 6:30 p.m.
MSD launches phase 3 Keytruda combo trial in tough-to-treat endometrial cancer in Korea - koreabiomed.com

MSD launches phase 3 Keytruda combo trial in tough-to-treat endometrial cancer in Korea koreabiomed.com

Published: May 30, 2025, 1:52 a.m.
The Kapil Sharma Show’s Sumona Chakravarti takes a fitness retreat in Bali; calls it ‘a massive personal challenge’ - Times of India

The Kapil Sharma Show’s Sumona Chakravarti takes a fitness retreat in Bali; calls it ‘a massive personal challenge’ Times of India

Published: May 29, 2025, 11:30 p.m.
The Kapil Sharma Show’s Sumona Chakravarti takes a fitness retreat in Bali; calls it ‘a massive personal - Times of India

The Kapil Sharma Show’s Sumona Chakravarti takes a fitness retreat in Bali; calls it ‘a massive personal Times of India

Published: May 29, 2025, 11:30 p.m.
Long-term Commitment to Treating Endometriosis and Improving Women's Quality of Life - Gedeon Richter at the World Congress on Endometriosis - The Malaysian Reserve

Long-term Commitment to Treating Endometriosis and Improving Women's Quality of Life - Gedeon Richter at the World Congress on Endometriosis The Malaysian Reserve

Published: May 29, 2025, 9:20 a.m.
Women suffering shameful and painful delays for NHS treatment - Sue Webber - Edinburgh News

Women suffering shameful and painful delays for NHS treatment - Sue Webber Edinburgh News

Published: May 29, 2025, 6 a.m.
To operate or not to operate? the impact of surgical treatment on quality of life in women with ovarian endometriosis - Frontiers

To operate or not to operate? the impact of surgical treatment on quality of life in women with ovarian endometriosis Frontiers

Published: May 28, 2025, 3:25 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!